Details for Patent: 12,042,494
✉ Email this page to a colleague
Which drugs does patent 12,042,494 protect, and when does it expire?
Patent 12,042,494 protects AKYNZEO and is included in one NDA.
This patent has sixty-eight patent family members in forty-one countries.
Drugs Protected by US Patent 12,042,494
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | METHOD OF TREATING EMESIS | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,042,494
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 3083 | ⤷ Subscribe | |||
| Australia | 2010320598 | ⤷ Subscribe | |||
| Brazil | 112012011485 | ⤷ Subscribe | |||
| Canada | 2778301 | ⤷ Subscribe | |||
| Chile | 2012001276 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
